Flavio Vincenti, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue, #M884D
San Francisco CA 94117
Phone415-353-1322
ORCID ORCID Icon0000-0002-6701-4680 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    I have been at UCSF since 1975 and on the faculty of the Department of Medicine in the division of Nephrology since 1976 and have been involved with the transplant service in patient care and clinical trials with novel immunosuppression drugs

    Collapse Research 
    Collapse Research Activities and Funding
    Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)
    NIH U01AI113362Jul 1, 2014 - May 31, 2024
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: results from a randomized phase 3 trial. Am J Transplant. 2024 Feb 20. Vincenti F, Bromberg J, Kim J, Faravardeh A, Leca N, Alperovich G, Csomor PA, Aslam S, Neylan J. PMID: 38387622.
      View in: PubMed   Mentions:    Fields:    
    2. Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant. J Am Soc Nephrol. 2024 Mar 01; 35(3):347-360. Vincenti F, Bestard O, Brar A, Cruzado JM, Seron D, Gaber AO, Ali N, Tambur AR, Lee H, Abbadessa G, Paul JA, Dudek M, Siegel RJ, Torija A, Semiond D, Lépine L, Ternes N, Montgomery RA, Stegall M. PMID: 38147137.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    3. State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs. Front Immunol. 2023; 14:1167741. Vincenti F, Angeletti A, Ghiggeri GM. PMID: 37503337; PMCID: PMC10368981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA. 2023 07 03; 330(1):33-42. Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA. PMID: 37279999; PMCID: PMC10245286.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    5. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. Cell Rep. 2023 07 25; 42(7):112682. Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Lee FE. PMID: 37355988; PMCID: PMC10391632.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    6. Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet. Am J Transplant. 2023 10; 23(10):1483-1484. Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP. PMID: 37394381.
      View in: PubMed   Mentions: 1     Fields:    
    7. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ. 2023 05 31; 381:e073654. Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prié D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A. PMID: 37257905; PMCID: PMC10231444.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors. Ann Transl Med. 2023 Jun 30; 11(9):315. Rashmi P, Sigdel TK, Rychkov D, Damm I, Da Silva AA, Vincenti F, Lourenco AL, Craik CS, Reiser J, Sarwal MM. PMID: 37404982; PMCID: PMC10316099.
      View in: PubMed   Mentions:
    9. Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses. bioRxiv. 2023 Jan 20. Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Eun-Hyung Lee F. PMID: 36711623; PMCID: PMC9882341.
      View in: PubMed   Mentions:
    10. Burden of neutropenia and leukopenia among adult kidney transplant recipients: A systematic literature review of observational studies. Transpl Infect Dis. 2023 Feb; 25(1):e14000. Raval AD, Kistler KD, Tang Y, Vincenti F. PMID: 36508475.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Transplant Direct. 2023 Feb; 9(2):e1436. Looney CM, Schroeder A, Tavares E, Garg J, Schindler T, Vincenti F, Redfield RR, Jordan SC, Busque S, Woodle ES, Khan J, Eastham J, Micallef S, Austin CD, Morimoto A. PMID: 36700064; PMCID: PMC9851678.
      View in: PubMed   Mentions:
    12. Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial. J Am Soc Nephrol. 2023 01 01; 34(1):145-159. Hricik DE, Armstrong B, Alhamad T, Brennan DC, Bromberg JS, Bunnapradist S, Chandran S, Fairchild RL, Foley DP, Formica R, Gibson IW, Kesler K, Kim SJ, Mannon RB, Menon MC, Newell KA, Nickerson P, Odim J, Poggio ED, Sung R, Shapiro R, Tinckam K, Vincenti F, Heeger PS. PMID: 36195441; PMCID: PMC10101585.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    13. Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia. Clin Transplant. 2022 04; 36(4):e14583. Brar S, Berry R, Raval AD, Tang Y, Vincenti F, Skartsis N. PMID: 34984735.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function. Front Immunol. 2021; 12:783282. Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, Vincenti F, Tang Q. PMID: 35003100; PMCID: PMC8732758.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    15. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial. J Am Soc Nephrol. 2021 12 01; 32(12):3252-3264. Budde K, Prashar R, Haller H, Rial MC, Kamar N, Agarwal A, de Fijter JW, Rostaing L, Berger SP, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F. PMID: 34706967; PMCID: PMC8638403.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    16. Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study. BMJ Open. 2021 10 07; 11(10):e052138. Aubert O, Divard G, Pascual J, Oppenheimer F, Sommerer C, Citterio F, Tedesco H, Chadban S, Henry M, Vincenti F, Srinivas T, Watarai Y, Legendre C, Bernhardt P, Loupy A. PMID: 34620664; PMCID: PMC8499283.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Tests for the noninvasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs. Am J Transplant. 2021 11; 21(11):3811. Danovitch GM, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall MD, Steiner RW, Stock PG, Vincenti F. PMID: 34080294.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells. Front Immunol. 2021; 12:679675. Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q. PMID: 34220826; PMCID: PMC8253048.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    19. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial. Am J Transplant. 2021 07; 21(7):2543-2554. Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG. PMID: 33331082.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    20. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation. Front Genet. 2020; 11:610682. Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM. PMID: 33469465; PMCID: PMC7813999.
      View in: PubMed   Mentions: 5  
    21. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. Am J Transplant. 2021 05; 21(5):1691-1698. Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES. PMID: 33128812; PMCID: PMC8246831.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Kidney Int Rep. 2021 Feb; 6(2):296-303. Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF. PMID: 33615054; PMCID: PMC7879201.
      View in: PubMed   Mentions: 3  
    23. The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: The critical role of maintenance treatment and inflammatory load. Clin Transplant. 2020 11; 34(11):e14084. Dobi D, Vincenti F, Chandran S, Greenland JR, Bowman C, Chen A, Junger H, Laszik ZG. PMID: 32939817; PMCID: PMC8059253.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    24. Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation. bioRxiv. 2020 Oct 06. Zarinsefat A, Hartoularos G, Chandran S, Yee CJ, Vincenti F, Sarwal MM. PMID: 32935096; PMCID: PMC7491509.
      View in: PubMed   Mentions:
    25. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci Transl Med. 2020 03 18; 12(535). Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM. PMID: 32188722; PMCID: PMC8289390.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    26. Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes. Transplantation. 2020 01; 104(1):54-60. Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F. PMID: 31449183; PMCID: PMC6933079.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    27. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Front Med (Lausanne). 2019; 6:213. Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. PMID: 31632976; PMCID: PMC6781675.
      View in: PubMed   Mentions: 13  
    28. A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation. Am J Transplant. 2020 01; 20(1):172-180. Vincenti F, Klintmalm G, Yang H, Ram Peddi V, Blahunka P, Conkle A, Santos V, Holman J. PMID: 31397943; PMCID: PMC6972670.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    29. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. Am J Transplant. 2019 11; 19(11):3035-3045. Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D. PMID: 31257724; PMCID: PMC6899639.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    30. Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. Transplant Rev (Orlando). 2019 10; 33(4):191-199. Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. PMID: 31377099.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. Am J Transplant. 2019 11; 19(11):3018-3034. Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J, TRANSFORM investigators. PMID: 31152476.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    32. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing. Nat Commun. 2019 04 23; 10(1):1906. Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM. PMID: 31015506; PMCID: PMC6479061.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    33. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clin Transplant. 2019 03; 33(3):e13487. Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F. PMID: 30689221.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial. Transplant Direct. 2018 Sep; 4(9):e380. Busque S, Vincenti FG, Tedesco Silva H, O'Connell PJ, Yoshida A, Friedewald JJ, Steinberg SM, Budde K, Broeders EN, Kim YS, Hahn CM, Li H, Chan G. PMID: 30234149; PMCID: PMC6133407.
      View in: PubMed   Mentions: 5  
    35. Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial. Transplant Direct. 2018 Jul; 4(7):e369. Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F. PMID: 30046659; PMCID: PMC6056278.
      View in: PubMed   Mentions:
    36. A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor. Am J Transplant. 2018 12; 18(12):2945-2954. Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C. PMID: 29745007.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    37. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. J Am Soc Nephrol. 2018 07; 29(7):1979-1991. Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F, TRANSFORM Investigators. PMID: 29752413; PMCID: PMC6050928.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    38. Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT. Clin Transplant. 2018 04; 32(4):e13225. Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP. PMID: 29461660.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    39. Targeted Transcriptional Profiling of Kidney Transplant Biopsies. Kidney Int Rep. 2018 May; 3(3):722-731. Sigdel TK, Nguyen M, Dobi D, Hsieh SC, Liberto JM, Vincenti F, Sarwal MM, Laszik Z. PMID: 29854981; PMCID: PMC5976814.
      View in: PubMed   Mentions: 13  
    40. Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. Transplant Proc. 2017 Oct; 49(8):1773-1778. Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. PMID: 28923623.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    41. Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly. Am J Transplant. 2017 Dec; 17(12):3219-3227. Vincenti F, Blancho G, Durrbach A, Grannas G, Grinyó J, Meier-Kriesche HU, Polinsky M, Yang L, Larsen CP. PMID: 28758341; PMCID: PMC5724691.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    42. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant. 2017 Nov; 17(11):2945-2954. Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. PMID: 28675676; PMCID: PMC5662482.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCellsCTClinical Trials
    43. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience. Clin Transplant. 2017 Sep; 31(9). Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F. PMID: 28662293.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Transplant trials with Tregs: perils and promises. J Clin Invest. 2017 Jun 30; 127(7):2505-2512. Tang Q, Vincenti F. PMID: 28665300; PMCID: PMC5490750.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    45. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. Am J Transplant. 2017 Oct; 17(10):2627-2639. Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA. PMID: 28371372; PMCID: PMC5620117.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    46. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2017 Sep; 2(5):800-810. Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J, Focal Segmental Glomerulosclerosis Study Group. PMID: 29270487; PMCID: PMC5733825.
      View in: PubMed   Mentions: 51  
    47. Belatacept: the challenges with transformational drugs. Transl Androl Urol. 2017 Apr; 6(2):341-342. Vincenti F. PMID: 28540252; PMCID: PMC5422674.
      View in: PubMed   Mentions:
    48. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant. 2017 05; 31(5). Wojciechowski D, Chandran S, Vincenti F. PMID: 28190259.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    49. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. Am J Kidney Dis. 2017 May; 69(5):587-594. Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N. PMID: 27889299.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    50. Current status of costimulatory blockade in renal transplantation. Curr Opin Nephrol Hypertens. 2016 11; 25(6):583-590. Wojciechowski D, Vincenti F. PMID: 27517137.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2. Adv Chronic Kidney Dis. 2016 09; 23(5):306-311. Wojciechowski D, Vincenti F. PMID: 27742385.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials. Am J Transplant. 2016 Nov; 16(11):3077-3078. Klintmalm GB, Vincenti F, Kirk A. PMID: 27232598.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 06 30; 374(26):2600-1. Vincenti F. PMID: 27355541.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    54. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed. Transplantation. 2016 Apr; 100(4):836-43. Webber AB, Vincenti F. PMID: 27003097.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    55. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 Jan 28; 374(4):333-43. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. PMID: 26816011.
      View in: PubMed   Mentions: 206     Fields:    Translation:HumansCTClinical Trials
    56. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. 2016 Jan; 100(1):184-93. Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. PMID: 26177089; PMCID: PMC4683035.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    57. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One. 2015; 10(9):e0138133. Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. PMID: 26367000; PMCID: PMC4569485.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    58. Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients. Am J Transplant. 2015 Jun; 15(6):1644-53. Vincenti F, Silva HT, Busque S, O'Connell PJ, Russ G, Budde K, Yoshida A, Tortorici MA, Lamba M, Lawendy N, Wang W, Chan G. PMID: 25649117.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    59. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med. 2014 Nov; 11(11):e1001759. Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Reed E, Sarwal MM. PMID: 25386950; PMCID: PMC4227654.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    60. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. PMID: 24676639; PMCID: PMC4073425.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    61. Clinical aspects: focusing on key unique organ-specific issues of renal transplantation. Cold Spring Harb Perspect Med. 2014 Feb 01; 4(2). Chandran S, Vincenti F. PMID: 24370927; PMCID: PMC3904099.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant. 2013 Nov; 13(11):2875-83. Rostaing L, Vincenti F, Grinyó J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragón-Ramirez GA, Kothari J, Pupim L, Larsen CP. PMID: 24047110.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    63. Tofacitinib in kidney transplantation. Expert Opin Investig Drugs. 2013 Sep; 22(9):1193-9. Wojciechowski D, Vincenti F. PMID: 23841583.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    64. Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma. Transpl Int. 2013 Sep; 26(9):938-48. van Gelder T, Baan C, Vincenti F, Mannon RB. PMID: 23822608.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    65. Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans. Transpl Int. 2013 May; 26(5):471-6. Vagefi PA, Qian JJ, Carlson DM, Aparici CM, Hirose R, Vincenti F, Wojciechowski D. PMID: 23384317.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    66. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. PMID: 23060281.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    67. Belatacept in kidney transplantation. Curr Opin Organ Transplant. 2012 Dec; 17(6):640-7. Wojciechowski D, Vincenti F. PMID: 23044530.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    68. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013 Jan; 13(1):136-45. Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H. PMID: 23137180; PMCID: PMC3563214.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    69. Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics. 2012; 6:385-93. Wojciechowski D, Vincenti F. PMID: 23152668; PMCID: PMC3496190.
      View in: PubMed   Mentions: 3  
    70. Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients. Transpl Int. 2012 Dec; 25(12):1257-67. Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F. PMID: 22994802.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    71. Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study. Transpl Int. 2012 Oct; 25(10):1059-64. Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N. PMID: 22816557.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    72. Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant. 2012 Sep; 12(9):2446-56. Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G. PMID: 22682022.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    73. Are calcineurin inhibitors-free regimens ready for prime time? Kidney Int. 2012 Nov; 82(10):1054-60. Vincenti F. PMID: 22622502.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. Beyond belatacept: praise and progress for the FDA. Am J Transplant. 2012 Mar; 12(3):513-4. Vincenti F. PMID: 22335245.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    75. Targeting JAK3 in kidney transplantation: current status and future options. Curr Opin Organ Transplant. 2011 Dec; 16(6):614-9. Wojciechowski D, Vincenti F. PMID: 21971513.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    76. C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity. Mod Pathol. 2012 Mar; 25(3):434-8. Jen KY, Nguyen TB, Vincenti FG, Laszik ZG. PMID: 22037262.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant. 2012 Jan; 12(1):210-7. Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, Charpentier B. PMID: 21992533.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    78. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2696-704. Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F. PMID: 21921152; PMCID: PMC3359571.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    79. Belatacept. Nat Rev Drug Discov. 2011 Aug 31; 10(9):655-6. Vincenti F, Dritselis A, Kirkpatrick P. PMID: 21878974.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    80. Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation. Semin Immunol. 2011 Jun; 23(3):157-64. Wojciechowski D, Vincenti F. PMID: 21856169.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    81. Novel strategies in immunosuppression: issues in perspective. Transplantation. 2011 May 27; 91(10):1057-64. Webber A, Hirose R, Vincenti F. PMID: 21412186.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    82. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation. 2011 May 15; 91(9):976-83. Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F. PMID: 21372756.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    83. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant. 2011 Jul; 11(7):1444-55. Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing KM, Abrams K, Witte S, Woodle ES. PMID: 21564523.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    84. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int. 2011 Jun; 79(11):1236-43. Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F. PMID: 21368745; PMCID: PMC3257033.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCTClinical Trials
    85. Response to questions regarding the design and results of the IMPACT trial. Am J Transplant. 2011 Jan; 11(1):177-8. Humar A, IMPACT Investigators Steering Committee, Peeters P, Abramowicz D, Humar A, Lebranchu Y, Hauser I, Jardine A, Limaye AP, Vincenti F, Punch JD, Blumberg E. PMID: 21199360.
      View in: PubMed   Mentions: 2     Fields:    
    86. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. Transplantation. 2010 Dec 27; 90(12):1427-31. Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P. PMID: 21197713.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    87. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation. 2010 Dec 27; 90(12):1521-7. Grinyó J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP. PMID: 21088650.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    88. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation. 2010 Dec 27; 90(12):1528-35. Larsen CP, Grinyó J, Medina-Pestana J, Vanrenterghem Y, Vincenti F, Breshahan B, Campistol JM, Florman S, Rial Mdel C, Kamar N, Block A, Di Russo G, Lin CS, Garg P, Charpentier B. PMID: 21076381.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    89. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation. 2010 Dec 27; 90(12):1595-601. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG. PMID: 20978464; PMCID: PMC4296579.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    90. How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept. Curr Opin Organ Transplant. 2010 Dec; 15(6):697-702. Wojciechowski D, Vincenti F. PMID: 20930638.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant. 2011 Jan; 11(1):66-76. Ferguson R, Grinyó J, Vincenti F, Kaufman DB, Woodle ES, Marder BA, Citterio F, Marks WH, Agarwal M, Wu D, Dong Y, Garg P. PMID: 21114656.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    92. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):430-9. Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J. PMID: 21051752; PMCID: PMC3052236.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    93. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis. 2010 Dec; 56(6):1127-39. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. PMID: 20934793.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    94. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant. 2010 Aug; 10(8):1870-80. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG. PMID: 20659093; PMCID: PMC2911648.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    95. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol. 2010 Sep; 21(9):1587-96. Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Mühlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B. PMID: 20634298; PMCID: PMC3013525.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    96. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010 May; 10(5):1228-37. Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P. PMID: 20353469.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCells
    97. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant. 2010 Mar; 10(3):535-46. Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP. PMID: 20415897.
      View in: PubMed   Mentions: 291     Fields:    Translation:HumansCTClinical Trials
    98. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant. 2010 Mar; 10(3):547-57. Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Mdel C, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J. PMID: 20415898.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansCTClinical Trials
    99. Kidney transplantation at UCSF: 8,300 transplants and onward. Clin Transpl. 2010; 161-7. Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O. PMID: 21696039.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases. Clin J Am Soc Nephrol. 2010 Jan; 5(1):142-51. Vincenti F, Cohen SD, Appel G. PMID: 20007678.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    101. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010 Feb; 77(4):299-311. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM, Kidney Disease: Improving Global Outcomes. PMID: 19847156.
      View in: PubMed   Mentions: 200     Fields:    Translation:Humans
    102. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. Am J Transplant. 2009 Aug; 9(8):1936-45. Busque S, Leventhal J, Brennan DC, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G. PMID: 19660021.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    103. Transplantation: To convert or not to convert: lessons from the CONVERT trial. Nat Rev Nephrol. 2009 Jul; 5(7):371-3. Bunnapradist S, Vincenti F. PMID: 19556993.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Kidney transplantation: the ideal immunosuppression regimen. Adv Chronic Kidney Dis. 2009 Jul; 16(4):226-33. Yabu JM, Vincenti F. PMID: 19576552.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    105. The AST's perspective on the proposed kidney allocation system. Am J Transplant. 2009 Jul; 9(7):1500. Murphy B, Vincenti F, Meier-Kriesche HU. PMID: 19459789.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. Transplantation. 2009 May 15; 87(9):1360-6. Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P. PMID: 19424036.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    107. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. PMID: 19443625; PMCID: PMC2709512.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    108. Evolving trends in induction therapy. Transplant Rev (Orlando). 2009 Apr; 23(2):94-102. Arias M, Campistol JM, Vincenti F. PMID: 19298940.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation. 2009 Mar 27; 87(6):926-33. Latek R, Fleener C, Lamian V, Kulbokas E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R. PMID: 19300198.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    110. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clin Pharmacokinet. 2009; 48(5):329-41. Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM. PMID: 19566116.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    111. What's next in the pipeline. Am J Transplant. 2008 Oct; 8(10):1972-81. Vincenti F, Kirk AD. PMID: 18828764.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    112. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant. 2008 Oct; 8(10):2086-96. Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F. PMID: 18828769; PMCID: PMC3087374.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCellsCTClinical Trials
    113. Tolerance versus immunosuppression: a perspective. Am J Transplant. 2008 Jul; 8(7):1365-6. Halloran PF, Bromberg J, Kaplan B, Vincenti F. PMID: 18557737.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    114. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int. 2008 Sep; 21(9):879-91. Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L. PMID: 18444945.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    115. Open letter to the FDA: new drug trials must be relevant. Am J Transplant. 2008 Apr; 8(4):733-4. Vincenti F, Klintmalm G, Halloran PF. PMID: 18324977.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant. 2008 Feb; 8(2):307-16. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J, FREEDOM Study Group. PMID: 18211506.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    117. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol. 2008 Feb; 121(2):299-306; quiz 307-8. Vincenti F. PMID: 18269922.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    118. Proteomics of plasma and urine in primary nephrotic syndrome in children. Contrib Nephrol. 2008; 160:17-28. Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A, Scolari F, Gusmano R, Carraro M, Zennaro C, Vincenti F, Ghiggeri GM. PMID: 18401158.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    119. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007. Clin J Am Soc Nephrol. 2008 Jan; 3(1):7-9. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Viecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) inve. PMID: 37001057.
      View in: PubMed   Mentions:    Fields:    
    120. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007. Clin J Am Soc Nephrol. 2008 01; 3(1):7-9. Ekberg H, Grinyo J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M, CAESAR study group. PMID: 37001118.
      View in: PubMed   Mentions:    Fields:    
    121. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant. 2008 Jan; 8(1):222-7. Yabu JM, Ho B, Scandling JD, Vincenti F. PMID: 17979998.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    122. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant. 2007 Jul; 7(7):1770-7. Vincenti F, Mendez R, Pescovitz M, Rajagopalan PR, Wilkinson AH, Butt K, Laskow D, Slakey DP, Lorber MI, Garg JP, Garovoy M. PMID: 17564637.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    123. Novel immunosuppression: small molecules and biologics. Semin Nephrol. 2007 Jul; 27(4):479-86. Yabu JM, Vincenti F. PMID: 17616278.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    124. Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. Br J Clin Pharmacol. 2007 Dec; 64(6):758-71. Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR. PMID: 17555465; PMCID: PMC2198786.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    125. Costimulation blockade--what will the future bring? Nephrol Dial Transplant. 2007 May; 22(5):1293-6. Vincenti F. PMID: 17460033.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    126. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007 Jun; 7(6):1506-14. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Inves. PMID: 17359512.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    127. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol. 2007 Mar; 2(2):198-9. Tomlanovich SJ, Vincenti F. PMID: 17699406.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    128. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol. 2007 Mar; 18(3):799-810. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM. PMID: 17287427.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    129. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant. 2007 Mar; 7(3):560-70. Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M. PMID: 17229079.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    130. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu Rev Med. 2007; 58:347-58. Vincenti F, Luggen M. PMID: 17020493.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    131. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature. Transplantation. 2006 Oct 27; 82(8):1004-12. Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, Vincenti F. PMID: 17060847.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    132. Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care. Am J Transplant. 2006 Oct; 6(10):2429-35. Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S. PMID: 16925565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Immunosuppression: today, tomorrow, and withdrawal. Semin Liver Dis. 2006 Aug; 26(3):201-10. Hirose R, Vincenti F. PMID: 16850369.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    134. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int. 2006 Jun; 19(6):446-57. Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada JM, Kumar MA, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N. PMID: 16771865.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    135. Antibodies come back to the forefront in transplantation. Clin J Am Soc Nephrol. 2006 May; 1(3):399. Vincenti F. PMID: 17699237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Transplantation. 2005 Oct 15; 80(7):910-6. Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R. PMID: 16249738.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    137. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S221-34. Land W, Vincenti F. PMID: 16251855.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    138. Rapidly developing nephrocalcinosis in a patient with end-stage liver disease who received a domino liver transplant from a patient with known congenital oxalosis. J Ultrasound Med. 2005 Oct; 24(10):1449-52. Aziz S, Callen PW, Vincenti F, Hirose R. PMID: 16179633.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    139. Current use and future trends in induction therapy. Saudi J Kidney Dis Transpl. 2005 Oct-Dec; 16(4):506-13. Vincenti F. PMID: 18202505.
      View in: PubMed   Mentions: 2     Fields:    
    140. Costimulation blockade with belatacept in renal transplantation. N Engl J Med. 2005 Aug 25; 353(8):770-81. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B, Belatacept Study Group. PMID: 16120857.
      View in: PubMed   Mentions: 243     Fields:    Translation:HumansCellsCTClinical Trials
    141. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant. 2005 Jun; 19(3):291-8. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M. PMID: 15877787.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    142. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant. 2005 Jun; 5(6):1179-85. Vincenti F, Ghiggeri GM. PMID: 15888021.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    143. A drug of the past, a lesson for the future. Pediatr Transplant. 2005 Jun; 9(3):267-8. Vincenti F. PMID: 15910379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    144. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplant Proc. 2005 Mar; 37(2):1001-4. Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B, DIRECT Study Group. PMID: 15848604.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    145. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant. 2005 Feb; 19(1):130-6. Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ. PMID: 15659146.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    146. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation. Contemp Clin Trials. 2005 Feb; 26(1):17-24. Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) inve. PMID: 15837449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant. 2005 Jan; 5(1):157-66. Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J. PMID: 15636625.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    148. Chronic induction. What's new in the pipeline. Contrib Nephrol. 2005; 146:22-29. Vincenti F. PMID: 15567917.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    149. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant. 2004 Dec; 4(12):2132-4. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. PMID: 15575919.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    150. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int. 2004 Sep; 17(8):395-401. Vincenti F. PMID: 15365604.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    151. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct; 8(5):231-3. Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. PMID: 15638236.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    152. A decade of progress in kidney transplantation. Transplantation. 2004 May 15; 77(9 Suppl):S52-61. Vincenti F. PMID: 15201687.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    153. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol Dial Transplant. 2004 May; 19(5):1036-40. Ghiggeri GM, Carraro M, Vincenti F. PMID: 15004256.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    154. Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys. Transplant Proc. 2004 Mar; 36(2 Suppl):50S-53S. Vincenti F, Brennan TV, Fuller TF, Feng S. PMID: 15041306.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    155. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation. 2004 Jan 15; 77(1):131-3. Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK. PMID: 14724448.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    156. Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation. Clin Transplant. 2003 Dec; 17(6):511-7. Pescovitz MD, Bumgardner G, Gaston RS, Kirkman RL, Light S, Patel IH, Nieforth K, Vincenti F. PMID: 14756266.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    157. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation. 2003 Jul 15; 76(1):190-5. Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. PMID: 12865808.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    158. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003 Jul; 3(7):835-45. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F. PMID: 12814475.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    159. Immunosuppression minimization: current and future trends in transplant immunosuppression. J Am Soc Nephrol. 2003 Jul; 14(7):1940-8. Vincenti F. PMID: 12819255.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    160. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplant Proc. 2003 May; 35(3 Suppl):183S-186S. Vincenti F, Stock P. PMID: 12742494.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    161. New monoclonal antibodies in renal transplantation. Minerva Urol Nefrol. 2003 Mar; 55(1):57-66. Vincenti F. PMID: 12773967.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    162. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant. 2003 Mar; 3(3):306-11. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. PMID: 12614286.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    163. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation. Am J Transplant. 2003 Jan; 3(1):50-2. Vincenti F, Pace D, Birnbaum J, Lantz M. PMID: 12492710.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    164. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant. 2002 Nov; 2(10):898-903. Vincenti F. PMID: 12482141.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    165. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002 Mar 15; 73(5):775-82. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. PMID: 11907427.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    166. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. J Clin Pharmacol. 2002 Mar; 42(3):304-11. Parasrampuria DA, Lantz MV, Birnbaum JL, Vincenti FG, Benet LZ. PMID: 11865967.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    167. Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens. Transplant Proc. 2001 Nov-Dec; 33(7-8):3169-71. Vincenti F. PMID: 11750360.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    168. Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function. Transplantation. 2001 Aug 27; 72(4):642-7. Bumgardner GL, Ramos E, Lin A, Vincenti F, Daclizumab Triple Therapy and Double Therapy Groups. PMID: 11544424.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    169. The role of newer monoclonal antibodies in renal transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1000-1. Vincenti F. PMID: 11267163.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    170. Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1011-2. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Neylan J, Roza A, Somberg K. PMID: 11267168.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    171. Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. Transplant Proc. 2001 Feb-Mar; 33(1-2):1019-20. Vincenti F. PMID: 11267172.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    172. Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors. Transplantation. 2000 Dec 27; 70(12):1707-12. Norman DJ, Vincenti F, de Mattos AM, Barry JM, Levitt DJ, Wedel NI, Maia M, Light SE. PMID: 11152101.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    173. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant. 2000 Dec; 14(6):550-4. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. PMID: 11127307.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    174. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. J Clin Pharmacol. 2000 May; 40(5):527-32. Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q. PMID: 10806606.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    175. The role of daclizumab in balancing resources for inpatient and outpatient transplant services. Prog Transplant. 2000 Mar; 10(1):21-4. Korsun A, Vincenti F, Ruck D, Whitelaw N, Ladoulis C, Whitelaw G. PMID: 10941323.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    176. Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis. Transpl Int. 2000; 13(2):151-9. Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F. PMID: 10836653.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    177. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation. 1999 Sep 15; 68(5):635-41. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V. PMID: 10507481.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    178. Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation. Transplant Proc. 1999 Sep; 31(6):2206-7. Vincenti F. PMID: 10500546.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    179. Potential of daclizumab in solid organ transplantation. BioDrugs. 1999 May; 11(5):333-41. Vincenti F. PMID: 18031143.
      View in: PubMed   Mentions: 2     Fields:    
    180. Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry. Transplant Proc. 1999 Feb-Mar; 31(1-2):223-4. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz C, Roza AM, Vincenti F, George V. PMID: 10083084.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    181. Can antibody prophylaxis allow sparing of other immunosuppressives? Transplant Proc. 1999 Feb-Mar; 31(1-2):1246-8. Vincenti F, Grinyo J, Ramos E, Nashan B, Stuart F, Kuypers D, Brattstrom C, Cho S, Ekberg H, Johnson R. PMID: 10083557.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    182. Review of transplantation--1999. Clin Transpl. 1999; 295-315. Hirose R, Vincenti F. PMID: 11038649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation. 1998 Dec 27; 66(12):1736-40. Solez K, Vincenti F, Filo RS. PMID: 9884269.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    184. Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups. Transplant Proc. 1998 Aug; 30(5):2155-8. Vincenti F, Nashan B, Light S. PMID: 9723424.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    185. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998 Apr 27; 65(8):1053-60. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. PMID: 9583865.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    186. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med. 1998 Jan 15; 338(3):161-5. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J. PMID: 9428817.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    187. Selection strategies for successful utilization of less than 15.kg pediatric donor kidneys. Transplant Proc. 1997 Dec; 29(8):3274-5. Bretan PN, Freise C, Goldstein R, Osorio R, Tomlanovich S, Amend W, Mathur V, Vincenti F. PMID: 9414712.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    188. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation. 1997 Apr 15; 63(7):977-83. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. PMID: 9112351.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCTClinical Trials
    189. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. Transplant Proc. 1997 Feb-Mar; 29(1-2):304-5. Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS. PMID: 9123008.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    190. Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplants. Transplantation. 1997 Jan 27; 63(2):233-7. Bretan PN, Friese C, Goldstein RB, Osorio RW, Tomlanovich S, Amend W, Mathur V, Vincenti F. PMID: 9020323.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    191. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Transplantation. 1997 Jan 15; 63(1):33-8. Vincenti F, Lantz M, Birnbaum J, Garovoy M, Mould D, Hakimi J, Nieforth K, Light S. PMID: 9000657.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    192. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation. 1996 Oct 15; 62(7):900-5. Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ. PMID: 8878381.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    193. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. PMID: 8830821.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    194. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation. 1996 Jun 15; 61(11):1576-81. Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ. PMID: 8669100.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    195. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996 Apr 04; 334(14):878-83. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F. PMID: 8596570.
      View in: PubMed   Mentions: 169     Fields:    Translation:HumansAnimals
    196. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients. Transplant Proc. 1996 Apr; 28(2):915-6. Stock PG, Lantz M, Light S, Vincenti F. PMID: 8623460.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    197. Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study. Transplantation. 1996 Feb 27; 61(4):573-7. Vincenti F, Danovitch GM, Neylan JF, Steiner RW, Everson MP, Gaston RS. PMID: 8610383.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    198. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation. 1996 Feb 15; 61(3):378-81. Lam PW, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferrell LD. PMID: 8610344.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    199. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation. 1995 Dec 15; 60(11):1215-9. Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ. PMID: 8525513.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    200. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplant. 1995 Apr; 9(2):119-24. Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F. PMID: 7599400.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    201. Phase II FK 506 multicenter concentration control study: one-year follow-up. Transplant Proc. 1995 Feb; 27(1):809-11. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A. PMID: 7533431.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    202. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995 Jan 27; 59(2):230-4. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, et al. PMID: 7839446.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    203. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis. 1994 Apr; 23(4):574-81. Artero ML, Sharma R, Savin VJ, Vincenti F. PMID: 8154495.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    204. Pentoxifylline reduces the first-dose reactions following OKT3. Transplant Proc. 1993 Apr; 25(2 Suppl 1):57-9. Vincenti FG, Vasconcelos M, Birnbaum JL, Tomlanovich SJ, Amend WJ, Melzer JS, Snyder JP. PMID: 8465428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    205. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation. 1993 Mar; 55(3):674-5. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C. PMID: 7681231.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    206. Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation. 1993 Feb; 55(2):273-6. Stempel CA, Lake J, Kuo G, Vincenti F. PMID: 7679527.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    207. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med. 1992 Apr; 92(4):375-83. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. PMID: 1558084.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    208. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation. 1992 Jan; 53(1):151-6. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP, et al. PMID: 1733064.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    209. Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients. Transplant Proc. 1991 Oct; 23(5):2651-2. Vincenti F, Weber P, Kuo G, Forsell J, Hunt S, Melzer J, Salvatierra O, Stempel C. PMID: 1656566.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    210. Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1251-2. Stempel C, Lake J, Ferrell L, Tomlanovich S, Amend W, Salvatierra O, Vincenti F. PMID: 1989202.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    211. Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol. Transplant Proc. 1991 Feb; 23(1 Pt 2):1024-6. Salvatierra O, McVicar J, Melzer J, Amend W, Vincenti F, Tomlanovich S, Husing R, Rabkin J, Garovoy M. PMID: 1989146.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    212. Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation. Transplantation. 1989 Apr; 47(4):595-8. Vincenti F, Biava C, Tomlanovitch S, Amend WJ, Garovoy M, Melzer J, Feduska N, Salvatierra O. PMID: 2650043.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    213. Successful management of the highly sensitized renal allograft recipient. Transplant Proc. 1989 Feb; 21(1 Pt 1):751-3. Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. PMID: 2650256.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    214. The incidence and impact of herpes simplex virus infections in the first month following renal transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 2):2091-2. Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O. PMID: 2652674.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    215. Immunologic alterations induced by donor-specific transfusion. Transplant Proc. 1989 Feb; 21(1 Pt 1):1171-2. Lockard-Marduel A, Gumbert M, Tomlanovich S, Amend W, Vincenti F, Schralla P, Melzer J, Feduska NJ, Salvatierra O, Garovoy MR. PMID: 2523120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    216. Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients. Transplant Proc. 1988 Jun; 20(3 Suppl 3):102-9. Feduska NJ, Melzer JS, Amend WJ, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O. PMID: 3291212.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc. 1988 Jun; 20(3 Suppl 4):285-8. Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, Salvatierra O. PMID: 3289209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    218. How to improve results for second renal allografts. Transplant Proc. 1988 Jun; 20(3 Suppl 3):176-9. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Lou C, Salvatierra O. PMID: 3291238.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    219. Posttransplant renal rejection: comparison of quantitative scintigraphy, US, and MR imaging. Radiology. 1987 Mar; 162(3):685-8. Hricak H, Terrier F, Marotti M, Engelstad BL, Filly RA, Vincenti F, Duca RM, Bretan PN, Higgins CB, Feduska N. PMID: 3544032.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    220. Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):2161-6. Feduska NJ, Perkins HA, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Garovoy M, Salvatierra O. PMID: 3547917.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    221. Sonography in the diagnosis of acute renal allograft rejection and cyclosporine nephrotoxicity. AJR Am J Roentgenol. 1987 Feb; 148(2):291-5. Linkowski GD, Warvariv V, Filly RA, Vincenti F. PMID: 3541547.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    222. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence? Transplant Proc. 1987 Feb; 19(1 Pt 3):1971-3. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. PMID: 2856274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    223. Donor-specific blood transfusions versus cyclosporine--the DST story. Transplant Proc. 1987 Feb; 19(1 Pt 1):160-6. Salvatierra O, Melzer J, Vincenti F, Amend WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ. PMID: 3547813.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    224. The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients. Transplantation. 1987 Jan; 43(1):61-4. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. PMID: 3541325.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    225. The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation. 1986 Nov; 42(5):511-5. Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, Vincenti F. PMID: 3538537.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    226. Renal allograft rejection: US evaluation. Radiology. 1986 Nov; 161(2):469-73. Hoddick W, Filly RA, Backman U, Callen PW, Vincenti F, Hricak H, Mahony BS, Amend W. PMID: 3532192.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    227. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months. Transplant Proc. 1986 Apr; 18(2 Suppl 1):136-40. Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O. PMID: 3515681.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    228. Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation? Braz J Med Biol Res. 1986; 19(3):355-66. Stabile C, Vincenti F, Garovoy M, Duca R, Melzer J, Feduska NJ, Salvatierra O, Amend WJ. PMID: 3297218.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    229. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Transplantation. 1985 Dec; 40(6):654-9. Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ. PMID: 3907038.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    230. Pharmacokinetics of sulfisoxazole in renal transplant patients. Antimicrob Agents Chemother. 1985 Oct; 28(4):535-9. Shermantine M, Gambertoglio J, Amend W, Vincenti F, Oie S. PMID: 3907496; PMCID: PMC180300.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    231. Dramatic improvement in the success rate for renal transplants in diabetic recipients with donor-specific transfusions. Transplantation. 1984 Dec; 38(6):704-8. Feduska NJ, Melzer J, Amend W, Vincenti F, Duca R, Garovoy M, Hopper S, Salvatierra O. PMID: 6390836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Peptic ulcer disease in kidney transplant recipients. Am J Surg. 1984 Jul; 148(1):51-7. Feduska NJ, Amend WJ, Vincenti F, Melzer JS, Duca R, Garovoy MR, Salvatierra O. PMID: 6377938.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    233. Parathyroid and bone response of the diabetic patient to uremia. Kidney Int. 1984 Apr; 25(4):677-82. Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ, Feduska NJ, Salvatierra O. PMID: 6482171.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    234. Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation. 1983 Dec; 36(6):626-9. Vincenti F, Amend WJ, Kaysen G, Feduska N, Birnbaum J, Duca R, Salvatierra O. PMID: 6659058.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    235. The role of blood transfusions in renal transplantation. Urol Clin North Am. 1983 May; 10(2):243-52. Salvatierra O, Vincenti F, Amend WJ, Garovoy MR, Potter D, Feduska NJ. PMID: 6190285.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    236. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation. 1983 Apr; 35(4):315-9. Berger BE, Vincenti F, Biava C, Amend WJ, Feduska N, Salvatierra O. PMID: 6340284.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    237. Furosemide assays and disposition in healthy volunteers and renal transplant patients. Fed Proc. 1983 Apr; 42(6):1695-8. Benet LZ, Smith DE, Lin ET, Vincenti F, Gambertoglio JG. PMID: 6339277.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    238. Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function. Am J Med. 1982 Oct; 73(4):475-81. O'Connor DT, Barg AP, Amend W, Vincenti F. PMID: 6751083.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    239. Blood transfusions before and on the day of transplantation: effects on cadaver graft survival. Transplant Proc. 1982 Jun; 14(2):302-4. Feduska NJ, Amend WJ, Vincenti F, Duca R, Salvatierra O. PMID: 7051470.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    240. Update of the University of California at San Francisco experience with donor-specific blood transfusions. Transplant Proc. 1982 Jun; 14(2):363-6. Salvatierra O, Iwaki Y, Vincenti F, Amend W, Terasaki P, Garovoy M, Duca R, Hopper S, Feduska N. PMID: 7051480.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    241. Blood transfusions and kidney transplantation. Arch Intern Med. 1982 Apr; 142(4):680-1. Vincenti F, Amend WJ, Feduska NJ, Salvatierra O. PMID: 6462121.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    242. Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int. 1982 Apr; 21(4):621-6. Gambertoglio JG, Frey FJ, Holford NH, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O, Amend WJ. PMID: 7047863.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    243. Prognostic features of early renal transplant rejections. Am J Kidney Dis. 1982 Mar; 1(5):281-7. Amend WJ, Vincenti F, Duca R, Feduska NJ, Cochrum K, Potter D, Salvatierra O. PMID: 7041637.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    244. Septic arthritis following renal transplantation. Nephron. 1982; 30(3):253-6. Vincenti F, Amend WJ, Feduska NJ, Salvatierra O. PMID: 7048116.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    245. Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions. Transplantation. 1981 Dec; 32(6):528-31. Salvatierra O, Iwaki Y, Vincenti F, Amend W, Potter D, Opelz G, Terasaki P, Duca R, Hopper S, Feduska N. PMID: 7041356.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    246. An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus. Transplantation. 1981 Dec; 32(6):517-21. Feduska NJ, Vincenti F, Amend W, Iwaki Y, Opelz G, Terasaki P, Duca R, Hopper S, Salvatierra O. PMID: 6461954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    247. Improved graft survival following donor-specific blood transfusions. Transplant Proc. 1981 Sep; 13(3):1657-61. Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Levin B, Sampson D, Feduska N, Salvatierra O. PMID: 7029829.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    248. Prevention of prednisone-induced negative nitrogen balance. Effect of dietary modification on urea generation rate in patients on hemodialysis receiving high-dose glucocorticoids. Ann Intern Med. 1981 Aug; 95(2):158-61. Cogan MG, Sargent JA, Yarbrough SG, Vincenti F, Amend WJ. PMID: 7258863.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    249. Furosemide kinetics and dynamics after kidney transplant. Clin Pharmacol Ther. 1981 Jul; 30(1):105-13. Smith DE, Gambertoglio JG, Vincenti F, Benet LZ. PMID: 7016396.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    250. 1,500 renal transplants at one center: evolution of a strategy for optimal success. Am J Surg. 1981 Jul; 142(1):14-20. Salvatierra O, Amend W, Vincenti F, Potter D, Stoney R, Duca R, Feduska N. PMID: 7020458.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    251. Recurrent systemic lupus erythematosus involving renal allografts. Ann Intern Med. 1981 Apr; 94(4 pt 1):444-8. Amend WJ, Vincenti F, Feduska NJ, Salvatierra O, Johnston WH, Jackson J, Tilney N, Garovoy M, Burwell EL. PMID: 7011137.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    252. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA. 1981 Mar 06; 245(9):930-3. Vincenti F, Hattner R, Amend WJ, Feduska NJ, Duca RM, Salvatierra O. PMID: 7007680.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    253. Improved graft survival with donor-specific transfusion pretreatment. Transplant Proc. 1981 Mar; 13(1 Pt 1):190-3. Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Feduska N, Salvatierra O. PMID: 7022820.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    254. Graft survival with high levels of cytotoxic antibodies. Transplant Proc. 1981 Mar; 13(1 Pt 1):73-80. Feduska NJ, Amend WJ, Vincenti F, Perkins HA, Opelz G, Terasaki PI, Iwaki Y, Duca R, Dodge D, Salvatierra O. PMID: 7022910.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    255. Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Transplant Proc. 1981 Mar; 13(1 Pt 1):142-9. Salvatierra O, Amend W, Vincenti F, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Hanes D, Cochrum KC, Hopper S, Feduska NJ. PMID: 6455788.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    256. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocrinol Metab. 1980 Sep; 51(3):561-5. Gambertoglio JG, Vincenti F, Feduska NJ, Birnbaum J, Salvatierra O, Amend WJ. PMID: 6997330.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    257. Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med. 1980 Jul; 69(1):107-12. Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra O. PMID: 6992574.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    258. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med. 1980 Mar; 68(3):363-9. Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra O. PMID: 6987872.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    259. Post-transplantation pyelonephritis: factors producing low patient and transplant morbidity. J Urol. 1980 Feb; 123(2):153-6. Pearson JC, Amend WJ, Vincenti FG, Feduska NJ, Salvatierra O. PMID: 6986476.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    260. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg. 1980; 192(4):543-52. Salvatierra O, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ. PMID: 6448588; PMCID: PMC1347002.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    261. The organization of a successful donor-specific transfusion protocol in related recipients with high MLC. Proc Clin Dial Transplant Forum. 1980; 10:272-6. Hopper S, Feduska N, Vincenti F, Amend W, Salvatierra O. PMID: 6180431.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    262. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts. Transplant Proc. 1979 Dec; 11(4):1903-7. Cochrum KC, Hanes D, Potter D, Vincenti F, Amend W, Feduska N, Perkins H, Salvatierra O. PMID: 161102.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    263. Results and significance of angiography in potential kidney donors. Radiology. 1979 Oct; 133(1):45-7. Spring DB, Salvatierra O, Palubinskas AJ, Amend WJ, Vincenti FG, Feduska NJ. PMID: 382250.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    264. The transplanted kidney as a source of hepatitis B infection. Ann Intern Med. 1979 Sep; 91(3):412-3. Wolf JL, Perkins HA, Schreeder MT, Vincenti F. PMID: 382937.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    265. Analysis of costs and outcomes of renal transplantation at one center. Its implications. JAMA. 1979 Apr 06; 241(14):1469-73. Salvatierra O, Feduska NJ, Vincenti F, Duca R, Potter D, Nolan J, Cochrum KC, Amend WJ. PMID: 372589.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    266. Comparative study of albumin solution and cryoprecipitated plasma for renal preservation: a preliminary report. Transplant Proc. 1979 Mar; 11(1):472-7. Feduska NJ, Collins GM, Amend WJ, Vincenti F, Duca RM, Stieper KW, Mitchell JW, Cochrum KC, Salvatierra O. PMID: 377678.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    267. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival. Transplant Proc. 1979 Mar; 11(1):404-10. Cochrum K, Hanes D, Van Speybroeck J, Perkins H, Ferrone S, Indeveri F, Amend W, Vincenti F, Feduska N, Salvatierra O. PMID: 156426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    268. The influence of donor age on graft survival. Am J Surg. 1979 Mar; 137(3):374-7. Speybroeck JV, Feduska N, Amend W, Vincenti F, Cochrum K, Salvatierra O. PMID: 373476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    269. Do blood transfusions enhance the possibility of a compatible transplant? Transplantation. 1979 Jan; 27(1):35-8. Feduska NJ, Vincenti F, Amend WJ, Duca R, Cochrum K, Salvatierra O. PMID: 375493.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    270. Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups. Proc Eur Dial Transplant Assoc. 1979; 16:419-25. Vincenti F, Amend W, Feduska N, Duca R, Salvatierra O. PMID: 398515.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    271. Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival. N Engl J Med. 1978 Oct 12; 299(15):793-8. Vincenti F, Duca RM, Amend W, Perkins HA, Cochrum KC, Feduska NJ, Salvatierra O. PMID: 151230.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    272. Leukocyte migration inhibitory factor (LIF) as an indicator of presensitization and allograft survival. Transplant Proc. 1978 Jun; 10(2):455-8. Cochrum KC, Haynes DM, Salvatierra O, Feduska NJ, Vincenti F, Van Speybroeck J. PMID: 150081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    273. The effect of hypothermic pulsatile perfusion on glomerular epithelial surface structures studied by scanning electron microscopy. Trans Am Soc Artif Intern Organs. 1978; 24:257-60. Vincenti F, Amend W, Feduska N, Maglio M, Axel L, Cochrum K, Salvatierra O. PMID: 716010.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    274. Hepatitis-B reactivation after renal transplantation. Lancet. 1977 Jun 18; 1(8025):1314. Denes AE, Berquist KR, Fields HA, Vincenti F. PMID: 68414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    275. Tumorous hyperparathyroidism in hypophosphatemic vitamin D--resistant rickets. J Med Liban. 1973; 26(6):583-94. Vincenti F, Hajjar ET, Salti IS. PMID: 4361307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    276. Renal vein renin in hypertension. Diagnostic and therapeutic implications. J Med Liban. 1973; 26(1):9-16. Vincenti F, Birbari A, Rizk G. PMID: 4718010.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Flavio's Networks
    Concepts (533)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (47)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.